Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2026 15:46 ET | Source: PATTERN COMPUTER, INC.

Pattern Expands Global Patent Protection for PCI020302 Across U.S., Mexico, Europe, and Australia

REDMOND, Wash., March 18, 2026 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in Pattern Discovery, today announced expanded global intellectual property...
March 18, 2026 08:36 ET | Source: AIM ImmunoTech Inc.

AIMイムノテック、アンプリジェンとチェックポイント阻害剤を併用する新規がん治療法の、日本における特許の最終承認を発表

フロリダ州オカラ発, March 18, 2026 (GLOBE NEWSWIRE) -- AIMイムノテック (AIM ImmunoTech Inc.) (NYSE American：AIM) (「AIM」または「同社」) は本日、日本特許庁が同社独自のアンプリジェン (Ampligen) (リンタトリモド) とチェックポイント阻害剤 (抗PD-1抗体または抗PD-L1抗体)...
March 18, 2026 08:36 ET | Source: AIM ImmunoTech Inc.

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

OCALA, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Japan Patent Office has fully approved a Japanese patent...
March 16, 2026 16:01 ET | Source: IPG Photonics Corporation

IPG Photonics Announces Ruling in Unified Patent Court

MARLBOROUGH, Mass., March 16, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP), the global leader in fiber laser technology, announced today that the Local Division of the Unified...
March 16, 2026 07:30 ET | Source: Palvella Therapeutics Inc.

Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

Patent strengthens global intellectual property protection for QTORIN™ rapamycin, Palvella’s lead product candidate from the QTORIN™ platform, in development for serious, rare skin diseases and...
March 13, 2026 07:45 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy

Innovative non-hallucinogenic approach combines MEAI with Palmitoylethanolamide to tackle major depressive disorder, addressing a surging market expected to surpass $25 billion by 2030 Vancouver,...
March 12, 2026 12:28 ET | Source: ZenaTech Inc.

ZenaDrone de ZenaTech anuncia la presentación de una patente para su sistema de defensa marítima que combina el dron interceptor ZenaDrone 2000 y la estación marina autónoma IQ Glider

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones tecnológicas especializado en drones con...
March 12, 2026 08:30 ET | Source: ZenaTech Inc.

ZenaTech’s ZenaDrone Announces the Filing of a Patent for its Maritime Defense System Combining ZenaDrone 2000 Interceptor Drone and IQ Glider Autonomous Marine Station

ZenaTech’s ZenaDrone Announces the Filing of a Patent for its Maritime Defense System Combining ZenaDrone 2000 Interceptor Drone and IQ Glider Autonomous M
March 12, 2026 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON Expands Patent Protection for Iadademstat with Grant Decision in Mexico Covering Combinations with PD-1/PD-L1 Inhibitors

Key combination for the treatment of Small Cell Lung Cancer MADRID and CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage...
March 10, 2026 19:25 ET | Source: Metalcloak (Armored Works, LLC)

MetalCloak Advances Off-Road Suspension with Expanded RockSport BLACK Line

Rancho Cordova, CA, March 10, 2026 (GLOBE NEWSWIRE) -- MetalCloak, the industry leader in high-performance suspension systems and precision off-road engineering, today announced the continued...